FDA Policy/General
Ardelyx Uses DTC Crackdown Lessons to Shape Ibsrela TV Ad
Ardelyx says it incorporated lessons from FDA's recent prescription drug advertising enforcement actions into its first television advertising campaign for Ibsrela (tenapanor), a treatment for irritable bowel syndrome with constipation (IBS-C). Specifically, the company says its new television commercial used static safety disclosures and simplified visuals to